Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$36.71

-1.61 (-4.20%)

16:21
11/06/18
11/06
16:21
11/06/18
16:21

Myriad Genetics reports Q1 adj. EPS 43c, consensus 30c

Reports Q1 revenue $202.3M, consensus $202.37M.

  • 06

    Nov

  • 06

    Nov

  • 14

    Nov

MYGN Myriad Genetics
$36.71

-1.61 (-4.20%)

10/10/18
PIPR
10/10/18
UPGRADE
Target $53
PIPR
Overweight
Myriad Genetics upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst William Quirk upgraded Myriad Genetics to Overweight and raised his price target for the shares to $53 from $38. After updating his reimbursement model for Myriad's Prolaris, Vectra, and GeneSight, the analyst believes the company has $9 of earnings per share power. Quirk now has increased confidence in Myriad's ability to beat Street expectations and admits he's been wrong on the shares.
11/01/18
PIPR
11/01/18
NO CHANGE
Target $53
PIPR
Overweight
Myriad Genetics should be bought on weakness, says Piper Jaffray
Piper Jaffray analyst William Quirk notes that Myriad Genetics' shares are off about 15% on two items, neither of which he believes will have a lasting effect on the company's business. First is an FDA safety communication about genetics tests used to predict drug response, he points out, adding that the letter "has teeth," but likely for consumer-oriented tests. The second is the 23&Me approval for a consumer-based pharmacogenomics test, which could certainly open up more testing, but within the consumer-driven, not physician-driven channel, he argues. Accordingly, Quirk recommends buying shares on the pullback, and reiterates an Overweight rating and $53 price target on the stock.
11/01/18
MSCO
11/01/18
NO CHANGE
MSCO
Myriad Genetics shares defended at Morgan Stanley
11/01/18
MSCO
11/01/18
NO CHANGE
MSCO
Overweight
Morgan Stanley says Myriad selloff on 23andMe approval a buying opportunity
Morgan Stanley analyst Steve Beuchaw said today's move lower in shares of Myriad Genetics "reflects confusion" on the regulatory backdrop for enetic tests and he believes the fact that 23andMe received an FDA approval yesterday for a consumer-facing pharmacogenetic screen is actually a positive for Myriad. Direct-to-consumer tests are not a substitute for clinical lab tests, as noted by the FDA, said Beuchaw, who believes uptake of consumer genomic tests, including their promotion by 23andMe, is a tailwind for Myriad and the category. He views the pullback as a buying opportunity and keeps an Overweight rating on Myriad Genetics shares.

TODAY'S FREE FLY STORIES

08:24
02/19/19
02/19
08:24
02/19/19
08:24
Conference/Events
Federal Reserve Bank of Cleveland president speaks on the economic outlook »

Cleveland Federal Reserve…

SRTS

Sensus Healthcare

$7.61

-0.13 (-1.68%)

08:23
02/19/19
02/19
08:23
02/19/19
08:23
Recommendations
Sensus Healthcare analyst commentary  »

Roth Capital establishes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLCO

Melco Resorts & Entertainment

$21.76

0.35 (1.63%)

08:23
02/19/19
02/19
08:23
02/19/19
08:23
Earnings
Melco Resorts & Entertainment reports Q4 EPS 27c, consensus 24c »

Reports Q4 revenue $1.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:23
02/19/19
02/19
08:23
02/19/19
08:23
Conference/Events
JPMorgan to hold a conference »

Taiwan CEO-CFO Conference…

UNIT

Uniti Group

$20.00

0.53 (2.72%)

08:22
02/19/19
02/19
08:22
02/19/19
08:22
Hot Stocks
Uniti Group issues statement on Windstream court ruling »

Uniti Group issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 11

    Mar

08:22
02/19/19
02/19
08:22
02/19/19
08:22
Conference/Events
Nomura to hold a conference »

Japan Corporate Day 2019…

WMT

Walmart

$100.00

1.52 (1.54%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

OXY

Occidental Petroleum

$67.17

0.62 (0.93%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Downgrade
Occidental Petroleum rating change  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 28

    May

NWL

Newell Brands

$17.15

-4.55 (-20.97%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Recommendations
Newell Brands analyst commentary  »

Newell Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

HAS

Hasbro

$86.43

-3.29 (-3.67%)

, FNKO

Funko

$18.05

-0.64 (-3.42%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Conference/Events
Jefferies to hold company meetings at conference »

Jefferies Company Hosted…

HAS

Hasbro

$86.43

-3.29 (-3.67%)

FNKO

Funko

$18.05

-0.64 (-3.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 28

    Feb

  • 06

    Mar

  • 28

    May

CAR

Avis Budget

$28.67

0.66 (2.36%)

, LAD

Lithia Motors

$87.98

4.05 (4.83%)

08:20
02/19/19
02/19
08:20
02/19/19
08:20
Hot Stocks
Avis Budget announces John North to be named CFO »

Avis Budget (CAR)…

CAR

Avis Budget

$28.67

0.66 (2.36%)

LAD

Lithia Motors

$87.98

4.05 (4.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

LH

LabCorp

$150.15

3.34 (2.28%)

08:19
02/19/19
02/19
08:19
02/19/19
08:19
Hot Stocks
LabCorp announces new assay in DoseASSURE portfolio »

LabCorp announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.00

1.52 (1.54%)

08:18
02/19/19
02/19
08:18
02/19/19
08:18
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart says operating in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

WMT

Walmart

$100.00

1.52 (1.54%)

08:17
02/19/19
02/19
08:17
02/19/19
08:17
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart sees pace of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

NVEE

NV5 Global

$76.56

0.49 (0.64%)

08:17
02/19/19
02/19
08:17
02/19/19
08:17
Hot Stocks
NV5 Global secures more than $11M in program management services »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

08:16
02/19/19
02/19
08:16
02/19/19
08:16
Conference/Events
Consumer Analyst Group of New York holds a conference »

CAGNY Conference 2019…

OXY

Occidental Petroleum

$67.17

0.62 (0.93%)

08:16
02/19/19
02/19
08:16
02/19/19
08:16
Downgrade
Occidental Petroleum rating change  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 28

    May

ECOR

ElectroCore

$6.82

-0.53 (-7.21%)

08:15
02/19/19
02/19
08:15
02/19/19
08:15
Hot Stocks
ElectroCore announces partnership with HealthyWomen »

ElectroCore announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.00

1.52 (1.54%)

08:14
02/19/19
02/19
08:14
02/19/19
08:14
Hot Stocks
Walmart says company needs to make more progress on profitability »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

MTFB

Motif Bio

$2.67

-0.14 (-4.98%)

08:14
02/19/19
02/19
08:14
02/19/19
08:14
Conference/Events
Motif Bio to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

MCO

Moody's

$169.20

5.72 (3.50%)

08:14
02/19/19
02/19
08:14
02/19/19
08:14
Recommendations
Moody's analyst commentary  »

Moody's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 09

    Apr

MRVL

Marvell

$18.82

-0.37 (-1.93%)

08:13
02/19/19
02/19
08:13
02/19/19
08:13
Upgrade
Marvell rating change  »

Marvell upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

EDRY

EuroDry

$7.85

-0.02 (-0.25%)

08:12
02/19/19
02/19
08:12
02/19/19
08:12
Earnings
EuroDry reports Q4 adj. EPS 31c, consensus 17c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

VSAT

ViaSat

$74.33

-0.6 (-0.80%)

08:12
02/19/19
02/19
08:12
02/19/19
08:12
Hot Stocks
EL AL Israel Airlines launches the Viasat in-flight Wi-Fi service »

Viasat announced EL AL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

MOTS

Motus GI Holdings

$4.49

0.19 (4.42%)

08:11
02/19/19
02/19
08:11
02/19/19
08:11
Hot Stocks
Motus GI Holdings announces publication of Pure-Vu system clinical study data »

Motus GI Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.